Research Article
SLC9A1 Binding mTOR Signaling Pathway-Derived Risk Score Predicting Survival and Immune in Clear Cell Renal Cell Carcinoma
Figure 6
Comparison of immunological characteristics of different risk groups and differences of 22 immune cell scores (a), stromal, immune, and ESTIMATE scores (b) of the high- and low-risk groups in TCGA cohort. (c) Immune checkpoint genes differentially expressed in different risk groups in TCGA cohort. (d) The TIDE analysis results of different risk groups in TCGA cohort. , , , and .
(a) |
(b) |
(c) |
(d) |